What is he best known for?
The fields of study he is best known for:
- Neurotransmitter
- Neuron
- Dopamine
The scientist’s investigation covers issues in Neuroscience, Dopamine, Glutamate receptor, Neurotransmitter and Neurotransmission.
He combines topics linked to Neurotensin with his work on Neuroscience.
His Dopamine study incorporates themes from Neuropeptide, Disease and Substance abuse.
The study incorporates disciplines such as Neurotrophic factors, Dopaminergic and Axon in addition to Glutamate receptor.
His Neurotransmitter research incorporates elements of Non-spiking neuron, Monoamine neurotransmitter and Glutamatergic.
His Neurotransmission study combines topics from a wide range of disciplines, such as Protein kinase A, GABAergic, Inhibitory postsynaptic potential, gamma-Aminobutyric acid and Cell biology.
His most cited work include:
- β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions (361 citations)
- From glutamate co-release to vesicular synergy: vesicular glutamate transporters (246 citations)
- Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation (222 citations)
What are the main themes of his work throughout his whole career to date?
Louis-Eric Trudeau focuses on Neuroscience, Dopamine, Dopaminergic, Glutamate receptor and Cell biology.
His Neuroscience research includes themes of Glutamatergic and Neurotransmission.
His research investigates the connection with Neurotransmission and areas like Biophysics which intersect with concerns in Electrophysiology.
His research investigates the connection between Dopamine and topics such as Neuron that intersect with issues in Endocrinology, Internal medicine and Midbrain.
Louis-Eric Trudeau combines subjects such as Synaptic vesicle, Biochemistry and Voltage-dependent calcium channel with his study of Cell biology.
The various areas that Louis-Eric Trudeau examines in his Neurotransmitter study include Acetylcholine and Cellular neuroscience.
He most often published in these fields:
- Neuroscience (60.77%)
- Dopamine (45.38%)
- Dopaminergic (20.77%)
What were the highlights of his more recent work (between 2017-2021)?
- Dopamine (45.38%)
- Neuroscience (60.77%)
- Substantia nigra (11.54%)
In recent papers he was focusing on the following fields of study:
Louis-Eric Trudeau spends much of his time researching Dopamine, Neuroscience, Substantia nigra, Ventral tegmental area and Dopaminergic.
His Dopamine research is multidisciplinary, incorporating elements of SYT7, Addiction and Neurotransmission.
Louis-Eric Trudeau focuses mostly in the field of Neuroscience, narrowing it down to matters related to Glutamate receptor and, in some cases, Neurotransmitter.
His study in Substantia nigra is interdisciplinary in nature, drawing from both Striatum, Neurotoxin and Neurodegeneration.
His research integrates issues of Parkin, MPTP and Cell biology in his study of Neurotoxin.
His Ventral tegmental area research is multidisciplinary, relying on both Ventral striatum and Neuron.
Between 2017 and 2021, his most popular works were:
- Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1 −/− mice (127 citations)
- On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. (90 citations)
- Glutamate Cotransmission in Cholinergic, GABAergic and Monoamine Systems: Contrasts and Commonalities. (31 citations)
In his most recent research, the most cited papers focused on:
- Neurotransmitter
- Neuron
- Dopamine
His main research concerns Dopamine, Neuroscience, Substantia nigra, Pars compacta and PINK1.
His research in Dopamine intersects with topics in Glutamate receptor, Cholinergic and Neurotransmitter.
The concepts of his Neuroscience study are interwoven with issues in Monoamine neurotransmitter, Vesicular transport protein and Neurodegeneration.
The Neurodegeneration study which covers Autophagy that intersects with Dopaminergic.
His Pars compacta study integrates concerns from other disciplines, such as Dopamine receptor, Dopamine receptor D2, Axon and Neurotransmission.
Louis-Eric Trudeau usually deals with PINK1 and limits it to topics linked to Mitochondrion and Neurotoxin, PARK7, LRRK2 and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
